Did you mean acetaminophen of aspirin and non ibuprofen?
Displaying drugs 13951 - 13975 of 14792 in total
Olinciguat
Olinciguat is under investigation in clinical trial NCT03892499 (A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers).
Investigational
Matched Description: … Olinciguat is under investigation in clinical trial NCT03892499 (A Trial to Evaluate the Effect of Itraconazole ... (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat …
TZP-102
TZP-102 is under investigation in clinical trial NCT01452815 (Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis).
Investigational
Matched Description: … of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis). ... TZP-102 is under investigation in clinical trial NCT01452815 (Affects of Once-daily Oral Administration …
INS 316
INS316 belongs to the family of drugs called nucleoside triphosphates.It is studied in the diagnosis of lung diseases, including lung cancer. It is selective P2y2 receptor antagonists claimed to be useful as anti-inflammatory agents.
Investigational
Matched Description: … of lung diseases, including lung cancer. ... INS316 belongs to the family of drugs called nucleoside triphosphates.It is studied in the diagnosis …
7-Deazaguanine
Experimental
LY-518674
LY518674 has been used in trials studying the treatment of Metabolic Syndrome X.
Investigational
Matched Description: … LY518674 has been used in trials studying the treatment of Metabolic Syndrome X. …
Fazadinium bromide
Experimental
Sarconeos
Sarconeos is an activator of the MAS receptor.
Investigational
Matched Description: … Sarconeos is an activator of the MAS receptor. …
GBR-12783
A selective inhibitor of dopamine uptake.
Investigational
Matched Description: … A selective inhibitor of dopamine uptake.[A252997] …
CRA_16847
Experimental
Rabeximod
Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis that is currently undergoing phase II clinical testing in eight European countries.
Investigational
Matched Description: … Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis …
N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE
Experimental
Displaying drugs 13951 - 13975 of 14792 in total